Lori Black v. HHS - Influenza, Guillain-Barré syndrome (GBS) (2024)

Lori Black filed a petition for compensation under the National Vaccine Injury Compensation Program, alleging that she suffered Guillain-Barré syndrome (GBS) as a result of an influenza vaccine administered on November 17, 2018. The respondent conceded that Ms.

Black was entitled to compensation, as her condition met the criteria for a Table injury. The case proceeded to a damages determination.

Ms. Black received the flu vaccine on November 17, 2018.

Approximately thirteen days later, she reported muscle and joint discomfort, reduced strength, and trouble walking. She was hospitalized, underwent diagnostic tests including a lumbar puncture and MRI, and received IVIg therapy.

A neurologist diagnosed her with inflammatory demyelinating polyradiculopathy (AIDP), which was confirmed by an EMG/NCS study. She was discharged to an inpatient rehabilitation facility and later attended physical therapy.

While her condition improved significantly, she continued to experience some fatigue and gait issues for approximately two years. The parties disagreed on the appropriate award for pain and suffering and unreimbursed medical expenses.

The court awarded Ms. Black $140,000.00 for pain and suffering, $1,087.37 for unreimbursed medical expenses, and $130.92 for travel expenses, totaling $141,218.29.

This award reflects a mild-to-moderate case of GBS with a relatively prompt diagnosis and treatment, leading to a good recovery but with some lingering symptoms.